EVIDENCE FOR SELECTIVE ACCUMULATION OF INTRATHYROIDAL LYMPHOCYTES-T IN HUMAN AUTOIMMUNE THYROID-DISEASE BASED ON T-CELL RECEPTOR V-GENE USAGE

被引:94
作者
DAVIES, TF
MARTIN, A
CONCEPCION, ES
GRAVES, P
LAHAT, N
COHEN, WL
BENNUN, A
机构
[1] LADY DAVIES CARMEL HOSP,DIV CLIN IMMUNOL,IL-34362 HAIFA,ISRAEL
[2] WEIZMANN INST SCI,IL-76100 REHOVOT,ISRAEL
关键词
HUMAN AUTOIMMUNE THYROID DISEASE; T-CELL RECEPTOR; V-GENE;
D O I
10.1172/JCI115556
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have investigated the T cell receptor V-alpha and V-beta gene family usage by T lymphocytes infiltrating affected thyroids in patients with autoimmune thyroid disease. We show that the intrathyroidal T lymphocytes from patients (n = 6) with autoimmune thyroid disease display a widespread usage of V-beta gene families with an average of 14.4/19 V-beta gene families similar to the peripheral T lymphocytes of the same patients. Because we recently reported that the utilization of V-alpha gene families is markedly reduced within these mitogen-stimulated intrathyroidal T cell populations, as well as within intact tissue from similar patients (n = 4) (overall mean of 4.0/18 families detected), these results indicate that in thyroids of patients with autoimmune thyroid disease the lymphocytes are selectively accumulating based on their V-alpha rather than V-beta elements. This preferential hTcR V-alpha and widespread V-beta gene usage was not mimicked in most 7-d autologous mixed lymphocyte reactions using non-T cell stimulators (n = 6) or EB-virus immortalized autologous B cell lines (n = 3). Hence, the selective V gene utilization by intrathyroidal T cells is likely to be secondary to multiepitopic thyroidal autoantigens activating thyroid infiltrating T cells or to the presence of a superantigenlike thyroidal self-antigen, capable of determining a selective infiltration or activation of a variety of T lymphocytes on the basis of their V-alpha gene usage.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 23 条
  • [1] BENNUN A, 1991, P NATL ACAD SCI USA, V88, P2466, DOI 10.1073/pnas.88.6.2466
  • [2] THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS
    BENNUN, A
    WEKERLE, H
    COHEN, IR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) : 195 - 199
  • [3] BOTH RAT AND MOUSE T-CELL RECEPTORS SPECIFIC FOR THE ENCEPHALITOGENIC DETERMINANT OF MYELIN BASIC-PROTEIN USE SIMILAR V-ALPHA AND V-BETA CHAIN GENES EVEN THOUGH THE MAJOR HISTOCOMPATIBILITY COMPLEX AND ENCEPHALITOGENIC DETERMINANTS BEING RECOGNIZED ARE DIFFERENT
    BURNS, FR
    LI, XO
    SHEN, N
    OFFNER, H
    CHOU, YK
    VANDENBARK, AA
    HEBERKATZ, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) : 27 - 39
  • [4] INTERACTION OF STAPHYLOCOCCUS-AUREUS TOXIN SUPERANTIGENS WITH HUMAN T-CELLS
    CHOI, YW
    KOTZIN, B
    HERRON, L
    CALLAHAN, J
    MARRACK, P
    KAPPLER, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8941 - 8945
  • [5] HUMAN AUTOIMMUNE THYROID-DISEASE - CELLULAR AND MOLECULAR ASPECTS
    DAVIES, TF
    MARTIN, A
    GRAVES, P
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1988, 2 (04): : 911 - 939
  • [6] COCULTURES OF HUMAN THYROID MONOLAYER CELLS AND AUTOLOGOUS T-CELLS - IMPACT OF HLA CLASS-II ANTIGEN EXPRESSION
    DAVIES, TF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (03) : 418 - 422
  • [7] EVIDENCE OF LIMITED VARIABILITY OF ANTIGEN RECEPTORS ON INTRATHYROIDAL T-CELLS IN AUTOIMMUNE THYROID-DISEASE
    DAVIES, TF
    MARTIN, A
    CONCEPCION, ES
    GRAVES, P
    COHEN, L
    BENNUN, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (04) : 238 - 244
  • [8] DAVIES TF, 1986, CLIN EXP IMMUNOL, V63, P73
  • [9] MICROSOMAL ANTIGEN-REACTIVE LYMPHOCYTE LINES AND CLONES DERIVED FROM THYROID-TISSUE OF PATIENTS WITH GRAVES-DISEASE
    FISFALEN, ME
    DEGROOT, LJ
    QUINTANS, J
    FRANKLIN, WA
    SOLTANI, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (04) : 776 - 784
  • [10] HIROSE W, 1988, J IMMUNOL, V141, P1098